Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance – CNBC

  1. Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance  CNBC
  2. Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products  Investors | Eli Lilly and Company
  3. Lilly’s (LLY) Sales Fall Short on Disappointing Zepbound Weight-Loss Drug Sales  Bloomberg
  4. Eli Lilly’s stock tumbles as Mounjaro, Zepbound sales miss expectations by wide margins  MarketWatch
  5. Eli Lilly Q3 earnings expected to beat Wall Street expectations  Yahoo Finance